Processa Pharmaceuticals, Inc. announced that James Stanker was appointed Chief Financial Officer on September 5, 2018. Mr. Stanker brings more than 25 years of financial and executive leadership experience to Processa in the areas of accounting principles and audit standards, regulatory reporting, and fiscal management and strategy. He has served in a financial leadership role as an audit partner at Grant Thornton, responsible for managing the audit quality in the mid-Atlantic area and more than 400 audit professionals, the Global Head of Audit Quality for Grant Thornton International, as well as Chief Financial officer for both a NASDAQ listed technology company and a privately-held life science company.